Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Elafibrano
GWQ ServicePlus AG awarded €1 to Ipsen Pharma GmbH for Healthcare & Medical in March 2025 — one of 207 awards this buyer has made, in line with its typical award size.
Buying agency
GWQ ServicePlus AGWinning supplier
Ipsen Pharma GmbHContract description
Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V zum Wirkstoff Elafibranor (Iqirvo)
Related awards · GWQ ServicePlus AG
207 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-131795-2026Novartis Pharma GmbH€125 Feb 2026 Healthcare
- ocds-ted-131852-2026neuraxpharm Arzneimittel GmbH€125 Feb 2026 Healthcare
- ocds-ted-133782-2026AstraZeneca GmbH€125 Feb 2026 Healthcare
Other wins · Ipsen Pharma GmbH
13 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-430178-2025DAK-Gesundheit€103 Jul 2025 Healthcare
- ocds-ted-319589-2026-2PBMG eGNot disclosed11 May 2026 Healthcare
- ocds-ted-319589-2026-3PBMG eGNot disclosed11 May 2026 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for GWQ ServicePlus AG and Ipsen Pharma GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back